Page last updated: 2024-10-26

doxepin and Erythroderma, Sezary

doxepin has been researched along with Erythroderma, Sezary in 1 studies

Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.

Research Excerpts

ExcerptRelevanceReference
"Extra-oral examination showed a painful lymphadenopathy on the right supraclavicular region."2.82Sézary syndrome: Report of a rare case with perioral manifestation and review of the literature. ( de Aquino, IG; Lopes, MA; Rodrigues-Fernandes, CI; Santos-Silva, AR; Vargas, PA, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rodrigues-Fernandes, CI1
Vargas, PA1
de Aquino, IG1
Lopes, MA1
Santos-Silva, AR1

Reviews

1 review available for doxepin and Erythroderma, Sezary

ArticleYear
Sézary syndrome: Report of a rare case with perioral manifestation and review of the literature.
    Oral oncology, 2022, Volume: 134

    Topics: Adrenal Cortex Hormones; Doxepin; Female; Folic Acid; Humans; Lymphadenopathy; Methotrexate; Middle

2022